Baseimmune, a UK-based startup leveraging AI for vaccine development against future pathogen mutations, secures £9M in Series A funding. The investment, led by MSD Global Health Innovation Fund and IQ Capital, underscores the growing focus on AI's potential in biotech, particularly for creating adaptable vaccines for pandemic preparedness.